Abstract Background Kidney transplantation (KTx) is a strong trigger for the development of
either recurrent or de novo atypical haemolytic uraemic syndrome (aHUS). According to …

Introduction Since 2016, kidney transplantation in patients with atypical hemolytic uremic
syndrome (aHUS) in the Netherlands is performed without eculizumab prophylaxis …

Atypical hemolytic uremic syndrome (aHUS) after kidney transplantation is rare and carries a
grave outcome. We present a single-center experience of all aHUS cases since the …

Atypical haemolytic uraemic syndrome (aHUS) often leads to end‐stage renal disease
(ESRD) and kidney transplantation; graft loss rates are high due to disease recurrence. A …

Rationale and objective Patients with atypical hemolytic uremic syndrome (aHUS) have long
been considered ineligible for kidney transplantation (KTx) in several centers due to the high …

Introduction Recurrence of atypical hemolytic uremic syndrome (aHUS) in renal allografts is
common, leading to dialysis and graft failure. Pretransplant versus posttransplant initiation of …

Background Atypical hemolytic uremic syndrome (aHUS) is an orphan disease with a high
rate of recurrence after kidney transplantation. However, reports of successful prevention of …

Background The development of complement inhibitors has greatly improved the outcome of
patients with atypical hemolytic uremic syndrome (aHUS), making kidney transplantation a …

In the last decade, significant progress has been made in the understanding and the
treatment of patients with atypical Hemolytic Uremic Syndrome (aHUS). aHUS has emerged …

Background: Kidney transplantation in patients with atypical hemolytic uremic syndrome
(aHUS) is frequently complicated by recurrence, resulting in thrombotic microangiopathy in …